Phase I Trial of Preoperative Radiotherapy With Concurrent Bevacizumab, Erlotinib and Capecitabine for Locally Advanced Pancreatic Cancer.
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Erlotinib (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 29 Jul 2016 Status changed from active, no longer recruiting to completed.
- 03 Mar 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jan 2018 as reported by ClinicalTrials.gov.
- 04 Sep 2014 Status changed from active, no longer recruiting to discontinued as reported by M.D.Anderson record.